Search

Author/Creator Shustov, Andrei R

2. Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study. Issue 11 (November 2021)

Authors:
Querfeld, Christiane; Thompson, John A; Taylor, Matthew H; DeSimone, Jennifer A; Zain, Jasmine M; Shustov, Andrei R; Johns, Carolyn; McCann, Sue; Lin, Gloria H Y; Petrova, Penka S; Uger, Robert A; Molloy, Naomi; Shou, Yaping; Akilov, Oleg E
Journal:
Lancet
Issue:
Volume 8:Issue 11(2021)
Page Start:
e808
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting. (October 2016)

Authors:
Gopal, Ajay K; Pro, Barbara; Connors, Joseph M; Younes, Anas; Engert, Andreas; Shustov, Andrei R; Chi, Xuedong; Larsen, Emily K; Kennedy, Dana A; Sievers, Eric L
Journal:
Clinical trials
Issue:
Volume 13:Number 5(2016)
Page Start:
545
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. Issue 4 (April 2020)

Authors:
Fox, Christopher P; Civallero, Monica; Ko, Young-Hyeh; Manni, Martina; Skrypets, Tetiana; Pileri, Stefano; Kim, Seok Jin; Cabrera, Maria Elena; Shustov, Andrei R; Chiattone, Carlos S; Horwitz, Steven M; Dlouhy, Ivan; Spina, Michele; Hitz, Felicitas; Montoto, Silvia; Nagler, Arnon; Martinez, Virgi...
Journal:
Lancet
Issue:
Volume 7:Issue 4(2020)
Page Start:
e284
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗